JPRN-UMIN000000961未知未知
Feasibility study of neoadjuvant chemotheray mFOLFOX6 for resectable liver metastases of colorectal cancers - Feasibility study of neoadjuvant chemotheray mFOLFOX6 for resectable liver metastases of colorectal cancers
Dept. Surgey Kyoto University Hospital0 个研究点目标入组 27 人开始时间: 2008年1月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Excluded are cases with conditions as below: 1) Peritoneal or pleural fluid retention to be drainaged. 2) Multiple malignancies to be treated. 3) Peripheral neural disturbances. 4) Active infectious diseases. 5) Severe watery diarrhea. 6) Mental disturbances. 7) Treatment history of continuous, oral or intravenous steroid therapy. 8) Previous history of ischemic heart diseases. 9) Coexistent severe diseases including pulmonary fibrosis, interstitial pneumonia, ileus, uncontrollable diabetes, cardiac dysfunction, hepatic failure, or renal failure. 10) Pregnant. 11) Previous history of severe drug-induced allergy.
研究者
相似试验
已完成
1 期
Feasibility study of adjuvant chemotherapy with FOLFOX(or XELOX) for 3 months followed by oral anticancer drug for 3 months in patients with completely resected colorectal cancerColorectal CancerJPRN-UMIN000004934PO Japan Southwest Oncology Research Support Organization(JSWOG)80
招募中
不适用
A feasibility study of neoadjuvant chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancerrectal cancerJPRN-UMIN000003428Toho University school of medicine20
已完成
不适用
Feasibility study of neoadjuvant chemotherapy with docetaxel/CDGP/5-fluorouracil in resectable esophagus canceresophagus cancerJPRN-UMIN000014305Department of Medical Oncology, Sapporo Medical University School of Medicine28
已完成
不适用
A feasibility study of neoadjuvant chemotherapy with docetaxel+cisplatin+capecitabine (DCX) for HER2-negative gastric cancer with macroscopic type 4 and large type 3, or with multiple lymph node metastasisGastric cancerJPRN-UMIN000026783agoya University20
已完成
2 期
Feasibility Study of Adjuvant Chemotherapy with UFT Following Stereotactic Body Radiation Therapy for Clinical Stage I Non-Small Cell Lung Cancer (LOGIK-1001)Clinical Stage I Non-small Cell Lung Cancer Treated with Stereotactic Body Radiation TherapyJPRN-UMIN000004789ung Oncology Group in Kyushu, Japan (LOGIK)45